Showing results (91-100 of 132) with videos related to
Sort By:
Pageof 14
The Journal of Thoracic and Cardiovascular Surgery|December 2, 2023
Lung resection after initial nonoperative treatment for non-small cell lung cancerElizabeth G Dunne, Cameron N Fick, Kay See Tan, et al.JAMA Oncology|May 29, 2020
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers: A Phase 1/2 Single-Group Open-Label TrialHelena A Yu, Adam J Schoenfeld, Alex Makhnin, et al.Cancer Immunology, Immunotherapy : CII|February 26, 2022
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitorsFyza Y Shaikh, Joell J Gills, Fuad Mohammad, et al.Journal for Immunotherapy of Cancer|July 24, 2023
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort studyArielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti, et al.International Journal of Radiation Oncology, Biology, Physics|December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation TrialAndreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2023
Initial Chemotherapy for Locally Advanced and Metastatic NUT CarcinomaJia Luo, Michelle Sanchez, Elinton Lee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2026
Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Non-Squamous Non-Small Cell Lung Cancer Treated with Chemoradiation and ImmunotherapyNikhil P Mankuzhy, Valentina Santo, Jacob Y Shin, et al.Proceedings of the National Academy of Sciences of the United States of America|June 8, 2018
<i>YES1</i> amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomicsPang-Dian Fan, Giuseppe Narzisi, Anitha D Jayaprakash, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 22, 2025
Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers With Different MET Exon 14 Skipping MutationsFederica Pecci, Prashasti Agrawal, Jessica S Ross, et al.JCO Precision Oncology|December 5, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma RegistrySara A Walton, Justin J Kim, Francesco Paoloni, et al.Pageof 14